Literature DB >> 203227

Large-scale production and concentration of infectious Epstein-Barr virus.

F Klein, J F Rosensteel, R M Hummer, E A Hillman, C W Riggs, L J Charmella.   

Abstract

Infectious Epstein-Barr virus (EBV) was produced from suspension cultures of P3HR-1 cells. A protocol for the scaled-up production and concentration of the virus was developed. Virus from the culture fluid was concentrated by continuous-flow pelletization or continuous flow with banding in sucrose. EBV prepared by pelletization yielded 1.7 X 10(4) infectious units/ml (100 X concentration) and less than 3.4 X 10(7) EVB particles/ml (1,000 X concentration), whereas EBV prepared by banding yielded 4.6 X 10(3) infectious units/ml (100 X concentration) aand 1.3 X 10(8) EBV particles 1 ml (1,000 X concentration). The majority of the virus particles observed were "empty" membrane-associated particles. A statistical test of the correlation between infectivity and virus particle count was made.

Entities:  

Mesh：

Year:  1978        PMID： 203227      PMCID： PMC242798          DOI： 10.1128/aem.35.1.172-178.1978

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN： 0099-2240            Impact factor:   4.792


  15 in total

1.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

Authors:  M A EPSTEIN; B G ACHONG; Y M BARR
Journal:  Lancet       Date:  1964-03-28       Impact factor: 79.321

2.  Concentration of Epstein-Barr virus from cell culture fluids with polyethylene glycol.

Authors:  A Adams
Journal:  J Gen Virol       Date:  1973-09       Impact factor: 3.891

3.  Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV.

Authors:  G Klein; B Sugden; W Leibold; J Menezes
Journal:  Intervirology       Date:  1974       Impact factor: 1.763

4.  Incidence of EB virus-containing cells in primary and secondary clones of several Burkitt lymphoma cell lines.

Authors:  B A Maurer; S M Wilbert; T Imamura
Journal:  Cancer Res       Date:  1970-12       Impact factor: 12.701

5.  Structure of critical point dried oncornaviruses.

Authors:  E De Harven; D Beju; D P Evenson; S Basu; G Schidlovsky
Journal:  Virology       Date:  1973-10       Impact factor: 3.616

6.  Large-volume purification of tumor viruses by use of zonal centrifuges.

Authors:  I Toplin; P Sottong
Journal:  Appl Microbiol       Date:  1972-05

7.  A precise method for replicating suspension cultures of mammalian cells.

Authors:  F J Weirether; J S Walker; R E Lincoln
Journal:  Appl Microbiol       Date:  1968-06

8.  Method for reproducible large-volume production and purification of Rauscher murine leukemia virus.

Authors:  R W Johnson; A Perry; O R Robinson; G P Shibley
Journal:  Appl Environ Microbiol       Date:  1976-02       Impact factor: 4.792

9.  Rapid semiquantitative method for screening large numbers of virus samples by negative staining electron microscopy.

Authors:  J H Monroe; P M Brandt
Journal:  Appl Microbiol       Date:  1970-08

10.  Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference.

Authors:  G Miller; J Robinson; L Heston; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205
View more
  3 in total

1.  New method for large-scale growth; and concentration of the Epstein-Barr viruses.

Authors:  G P Shibley; M Manousos; K Munch; I Zelljadt; L Fisher; S Mayyasi; K Harewood; R Stevens; K E Jensen
Journal:  Appl Environ Microbiol       Date:  1980-12       Impact factor: 4.792

2.  A virus-like particle-based Epstein-Barr virus vaccine.

Authors:  Romana Ruiss; Simon Jochum; Gerhard Wanner; Gilbert Reisbach; Wolfgang Hammerschmidt; Reinhard Zeidler
Journal:  J Virol       Date:  2011-10-12       Impact factor: 5.103

3.  PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity.

Authors:  Wen Zheng; Yuhuan Gao; Xiaoyan Ke; Weijing Zhang; Liping Su; Hanyun Ren; Ningjing Lin; Yan Xie; Meifeng Tu; Weiping Liu; Lingyan Ping; Zhitao Ying; Chen Zhang; Lijuan Deng; Xiaopei Wang; Yuqin Song; Jun Zhu
Journal:  BMC Cancer       Date:  2018-09-21       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.